We market over 25 vaccines worldwide to prevent potentially life-threatening or crippling illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis.
The majority of our vaccine R&D activities are conducted at GlaxoSmithKline Biologicals in Rixensart, Belgium. Over 1300 of our research scientists are devoted to developing new vaccines and more cost-effective and convenient combination vaccines to prevent infections that cause serious medical problems worldwide.
We are also targeting therapeutic vaccines that may prevent relapse in cancer patients. The strength of our vaccine pipeline will provide opportunities for us to consistently deliver new vaccines for many years to come.
Here you will find the Patient Information Leaflets or Prescribing Information for our vaccines. Please note that this information is often specific to a country or region and is not intended to replace the advice of a qualified doctor.
Products are in various stages of approval around the world and may not be available in every country.
Back to top 

This section contains information in several formats:
To download PDF files you will need Adobe Reader. If you do not have it installed, it is available free from the Adobe website. PDF links on this site open in a new window.
For audio-visual content you can use either Windows Media Player or Real Player, which can be installed free from their respective websites.